Diseases in Biological Technology

Repligen Reports First Quarter Fiscal Year 2010 Financial Results

... is important in the diagnosis and treatment of diseases such as acute and chronic pancreatitis. This ... expedite the review of drugs that treat serious diseases and fill an unmet medical need. There are more ... for the treatment of inherited neurodegenerative diseases such as Friedreich's ataxia. Preclinical studies ...

NewBridge Pharmaceuticals Announces Licensing of Pylera(R) for Middle East, Africa, Turkey & Caspian Region

... pylori is believed to cause a spectrum of diseases in humans, including gastritis, ulcer disease ... and Caspian regions to address the unmet needs of diseases with high regional prevalence such as cancer, diabetes, obesity, cardiovascular diseases and other metabolic disorders. NewBridge ...

AFFiRiS AG: 1st Place in Venture Capital & Private Equity Awards for MIG Fonds and AFFiRiS

... and atherosclerosis - in other words, against diseases that have so far seemed unsuitable for treatment ... for four further undisclosed chronic diseases are currently being developed by AFFiRiS AG. ... atherosclerosis, Parkinson's disease and other diseases that urgently require a medical solution and that ...

Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results

... is important in the diagnosis and treatment of diseases such as acute and chronic pancreatitis. This ... expedite the review of drugs that treat serious diseases and fill an unmet medical need. There are more ... for the treatment of inherited neurodegenerative diseases such as Friedreich's ataxia and Huntington's ...

Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus

... ) and the Division of Microbiology and Infectious diseases (DMID) of the National Institute of Allergy and Infectious diseases (NIAID), National Institutes of Health (NIH) have ... vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus like ...

AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support

... is clearly evident from the relevant figures - diseases of the cardiovascular system are the number ... announced the development of vaccines for three diseases - Alzheimer's, Parkinson's and ... atherosclerosis, Parkinson's disease and other diseases that urgently require a medical solution and for ...

CEL-SCI Developing Immune-Based Treatment Against Swine and Other H1N1 Flu Viruses Using Proprietary L.E.A.P.S. Technology

... induced protection and/or improvement in diseases as diverse as rheumatoid arthritis, malaria, TB ... can be successfully applied to many different diseases and these results further suggest that L.E.A.P.S. ... as infectious, parasitic, malignant or autoimmune diseases and allergies, are potential therapeutic or ...

ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week

... system response underlying inflammatory bowel diseases by blocking the CCR9 chemokine receptor. ... and intended for subsequent development to treat diseases such as Type 2 diabetes, multiple sclerosis and ... testing, being developed for inflammatory diseases such as rheumatoid arthritis. ChemoCentryx also ...

Oncothyreon's PX-866 is effective in preclinical model of pulmonary fibrosis

... to play an important role in a number of human diseases that cause fibrosis, or scarring, of the lungs," said Dr. Hardie. "Our model in mice mimics these diseases by activating this pathway in the lungs with a ... pathway might be beneficial in such human lung diseases as idiopathic pulmonary fibrosis." "Although ...

ROCK STARS OF SCIENCE: Prana's Co-Founding Scientist, Rudy Tanzi Teams up with Star-Powered Cast in GQ Photoshoot

... the MassGeneral Institute for Neurodegenerative diseases , will be featured in a six-page photo spread, ... a vital role in the development of treatments for diseases such as cancer, HIV and Alzheimer's disease, are ... we will be able to raise the funds needed to cure diseases like Alzheimer's," commented Dr. Tanzi. One ...

The Institut Pasteur and Merieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases

... their resources and efforts to fight infectious diseases through major research projects, spanning the ... collaboration in the fight against infectious diseases in developing countries. This includes research ... dedicated to the prevention and treatment of diseases through biological research, education and ...

Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting

... patients with Alzheimer's and Parkinson's diseases from "normal" individuals and patients with other ... test results for both Alzheimer's and Parkinson's diseases are being conducted with key clinical centers. At ... cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and ...

Neurocrine Biosciences Reports First Quarter 2009 Results

... antagonists in treating other hormone-dependent diseases in men's and women's health. Corticotropin ... company focused on neurological and endocrine diseases and disorders. Our product candidates address ... and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news ...

Sequella Commences Phase 1B Study for New Tuberculosis Drug SQ109

... biopharmaceutical company focused on diseases of epidemic potential, announced today the start ... the National Institute of Allergy and Infectious diseases (NIAID), part of the National Institutes of ... on commercializing improved treatments for diseases of epidemic potential. The company leverages its ...

ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist

... which is associated with the onset of autoimmune diseases such as lupus and certain types of vasculitis, ... to addressing inflammatory and autoimmune diseases to ChemoCentryx's pharmaceuticals portfolio," ... and intended for subsequent development to treat diseases such as Type 2 diabetes, multiple sclerosis and ...

Swine Flu Fears Generate Interest in UV Disinfection Technologies...Again

... Flu (all types), are highly contagious airborne diseases spread through contact with respiratory ... useful in the broader effort to combat contagious diseases such as flu, SARS, tuberculosis and cold viruses. ... (to included ... respiratory diseases could be ... Lumalier ...

CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease

... the 11th annual National Foundation of Infectious diseases Conference in Baltimore which demonstrates how ... maturing dendritic cell vaccines for infectious diseases such as pandemic flu and cancer. Dr. ... as infectious, parasitic, malignant or autoimmune diseases and allergies, are potential therapeutic or ...

NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza

... and Chief of the Division of Pediatric Infectious diseases at the University of Utah Health Sciences ... J. Joseph Adorjan Endowed Professor of Infectious diseases and Immunology; Professor of Medicine, Pediatrics ... the National Institute of Allergy and Infectious diseases (NIAID), part of the National Institutes of ...

Chimerix Joins International Network of Organizations to Cure Malaria

... compounds active against a broad range of viral diseases that we believe may be valuable in identifying ... and develop new and affordable medicines for the diseases of poverty in Africa. The company is funded by ... research focal point in Africa for infectious diseases including HIV, tuberculosis, malaria and their ...

CeNeRx BioPharma Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors

... and commercializing innovative treatments for diseases of the central nervous system (CNS), today ... and could potentially be applied to important diseases with significant unmet need," said Barry Brand, ... and commercializing innovative treatments for diseases of the central nervous system. CeNeRx's most ...

Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India

... of several other VLP vaccine candidates against diseases of public health concern in that region, such as ... vaccines against influenza and other infectious diseases within the region and globally." About ... suited to the development of vaccines against diseases endemic to India and the surrounding regions, ...

Otonomy Introduces Scientific Advisory Board

... Physicians and Researchers Specializing in Ear diseases to Guide Novel Treatments to Clinic SAN ... and research scientists specializing in diseases and disorders of the ear. The advisory ... integral to the development of new therapies for diseases that are currently untreatable, such as Meniere's ...

Publication of Shire plc's Annual Report 2008

... products for the treatment of rare genetic diseases such as REPLAGAL and ELAPRASE, may be high ... business on ADHD, HGT and gastrointestinal ('GI') diseases as well as opportunities in other therapeutic ... system. Treatments for GI diseases LIALDA/MEZAVANT for the maintenance of ...

Cytopia Scientific Presentation on JAK2 Inhibitor Program at American Chemical Society Conference

... on developing a therapy for these diseases through selective inhibition of JAK2. To successfully address these chronic diseases with a JAK2 inhibitor, the specificity and ... to be up-regulated, and for cardiovascular diseases such as pulmonary hypertension. For more ...

Frost & Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic Therapies

... or diseased. This is true, in particular, for diseases of the posterior of the eye. "Novagali ... Novasorb is optimized to treat a number of diseases by improving drug delivery to the front of the ... implant technology in treating challenging diseases of the eye's posterior." Novasorb is a ...

Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update

... -- Dimebon in both Alzheimer's and Huntington's diseases and MDV3100 for castration-resistant prostate ... Conference on Alzheimer's and Parkinson's diseases (AD/PD) held last week. Results showed Dimebon to ... of novel small molecule drugs to treat serious diseases for which there are limited treatment options. ...

Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

... ability to improve sleep in a wide variety of diseases where sleep improvement may be beneficial." ... impairment and schizophrenia) and neurological diseases (e.g. Parkinson's and Alzheimer's diseases). ... developing novel drugs for the treatment of diseases and disorders of the Central Nervous System ....

Infectious Diseases Company, Sequella, to Present at Upcoming European Conferences

... Infectious diseases Company Featured on March 9th and 10th, ... on commercializing products for infectious diseases of epidemic potential has announced that Alan ... 2, 2nd floor, as part of the CNS & Infectious diseases section of BioSquare 2009 at the Lyon Congress ...

PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting

... at the 7th Annual ASM Biodefense and Emerging diseases Research Meeting, being held in Baltimore, MD, ... About the ASM Biodefense and Emerging diseases Research Meeting The 7th Annual ASM Biodefense and Emerging diseases Research Meeting held in Baltimore, Maryland, is ...

Obio Pharmaceutical Announces Product Growth Strategy

... on the globally prevalent but underserved diseases such as diabetes and influenza." Amongst ... commercialize novel medicines for the underserved diseases affecting millions of patients worldwide." ... commercialize novel medicines for the underserved diseases affecting millions of patients worldwide. Obio is ...

Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609

... biopharmaceutical company focused on diseases of epidemic potential, today announced the ... the National Institute of Allergy and Infectious diseases (NIAID), National Institutes of Health (NIH), to ... develop new antibiotics for important infectious diseases that impact U.S. public health." About ...

Researchers at the University of Georgia Discover Protein is Crucial to Reproduction of Parasites Involved in Disease

... that can be used in studying other parasitic diseases and could one day lead to an effective target for ... Athens, GA (Vocus) February 12, 2009 -- As diseases go, toxoplasmosis is a wolf in sheep's clothing. ... that can be used in studying other parasitic diseases and could one day lead to an effective target for ...

GeoVax Update Provided at the BIO CEO & Investor Conference 2009

... company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) ... the National Institute of Allergy and Infectious diseases (NIAID), a division of the NIH. GeoVax is also ... license and commercialize human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) ...

Repligen Reports Third Quarter Fiscal Year 2009 Financial Results

... is important in the diagnosis and treatment of diseases such as acute and chronic pancreatitis. This ... expedite the review of drugs that treat serious diseases and fill an unmet medical need. There are more ... treating progressive, inherited neurodegenerative diseases such as Friedreich's ataxia and Huntington's ...

International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia"

... it also increases the accuracy with which diseases can be monitored, thus improving the overall ... of patients suffering from autoimmune diseases (caused when the body is unable to distinguish between foreign and self). Many common diseases such as Rheumatoid Arthritis are ...

AMT CEO Ronald Lorijn Steps Down

... patients suffering from serious, debilitating diseases by making gene therapy available to them", said ... our drug candidates into cures for serious diseases together with the team of excellent and ... promise for thousands of rare (orphan) diseases that are caused by one faulty gene. AMT currently ...

Parion Sciences Receives NIH Biodefense Grant to Study Novel Methods for Mitigating Radiation-Induced Lung Injury

... the National Institute of Allergy and Infectious diseases (NIAID), National Institutes of Health (NIH) and ... an innovative pipeline of therapies for diseases resulting from the failure of the body's mucosal ... at LRRI are committed to eradicating respiratory diseases through research aimed at understanding ...

Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411

... to develop ENaC inhibitors to treat a range of diseases through restoring and maintaining the ... an innovative pipeline of therapies for diseases resulting from the failure of the body's mucosal ... care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, ...

IDRI and Immune Design Corp. Enter License Agreement on GLA Vaccine Adjuvant

... Focusing on its mission to fight infectious diseases of the developing world, IDRI retains worldwide exclusive rights to GLA for selected diseases affecting predominately the developing world. ... we also think that it has great potential against diseases outside our scope of action," said Curt Malloy, ...

UCF professor develops vaccine to protect against black plague bioterror attack

... Army Medical Research Institute of Infectious diseases in Maryland. It is one of a few labs in the world ... his life to finding treatments and cures to diseases that ravage poor countries. He is conducting research into seven of the top 10 diseases ranked by the World Health Organization and the ...